McCormack et al randomized 89 women with lymphangioleiomyomatosis to receive 2 mg rapamycin or placebo daily for 12 months, followed by 12 months of drug-free observation.
Sirolimus was helpful for LAM, but with toxicity (RCT)
Sirolimus was helpful for LAM, but with…
Sirolimus was helpful for LAM, but with toxicity (RCT)
McCormack et al randomized 89 women with lymphangioleiomyomatosis to receive 2 mg rapamycin or placebo daily for 12 months, followed by 12 months of drug-free observation.